|
Children's Oncology Group Chair's Grant
|
5U10CA098543-05
|
$29,944,122
|
$15,870,385
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-43
|
$11,526,509
|
$115,265
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Regional Oncology Research Center
|
5P30CA006973-45
|
$7,564,613
|
$226,938
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
5P30CA014236-33
|
$6,558,287
|
$131,166
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Comprehensive Cancer Center Core Support Grant
|
5P30CA013148-36
|
$5,898,083
|
$117,962
|
PARTRIDGE, EDWARD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Children's Oncology Group Statistics and Data Center
|
5U10CA098413-05
|
$5,859,839
|
$3,105,715
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
St.Jude Children's Cancer Center Support Grant (CCSG)
|
3P30CA021765-29S2
|
$5,331,937
|
$693,152
|
KASTAN, MICHAEL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant
|
5P30CA068485-12
|
$5,179,933
|
$51,799
|
Pietenpol, Jennifer
|
VANDERBILT UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
2P30CA060553-14
|
$5,033,724
|
$151,012
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-13
|
$4,654,448
|
$930,890
|
Robison, Leslie
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant
|
5P30CA091842-07
|
$3,978,214
|
$39,782
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant P30 CA77598-06
|
5P30CA077598-10
|
$3,404,916
|
$102,147
|
YEE, DOUGLAS
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Cancer Center Support Grant
|
5P30CA023108-29
|
$3,012,185
|
$30,122
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Bone Marrow Transplantation in Human Disease
|
2P01CA015396-32A1
|
$2,857,642
|
$857,293
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer Center Support (Core) Grant
|
5P30CA014051-36
|
$2,815,899
|
$28,159
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Radiologial Physics Center
|
5U10CA010953-39
|
$2,431,121
|
$218,801
|
IBBOTT, GEOFFREY
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support Grant
|
5P30CA022453-26
|
$2,427,748
|
$145,665
|
RUCKDESCHEL, JOHN
|
WAYNE STATE UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA033572-24
|
$2,274,248
|
$68,227
|
KRONTIRIS, THEODORE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes
|
Z01 CP010144
|
$2,033,740
|
$1,069,850
|
Greene
|
DCEG (NCI)
|
|
Molecular Pathways to Thymic Lymphoma and Leukemia
|
5P01CA109901-04
|
$1,958,333
|
$979,167
|
LOOK, A
|
DANA-FARBER CANCER INSTITUTE
|
|
Quality Assurance Review Center
|
2U10CA029511-28
|
$1,871,106
|
$168,400
|
FITZGERALD, THOMAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Pediatric Oncology Branch Clinical Care and Education
|
Z01 BC 010764
|
$1,869,714
|
$373,943
|
Wayne, Alan
|
CCR (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
Z01 CP010131
|
$1,766,702
|
$357,732
|
Ron
|
DCEG (NCI)
|
|
Roles and Regulation of p53
|
5P01CA087497-07
|
$1,583,080
|
$79,154
|
Prives, Carol
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Stanford University Cancer Center
|
1P30CA124435-01
|
$1,500,000
|
$15,000
|
WEISSMAN, IRVING
|
STANFORD UNIVERSITY
|
|
Drug Development and Clinical Pharmacology of Anticancer Drugs for Childhood Canc
|
Z01 SC 006880
|
$1,453,500
|
$290,700
|
Balis, Frank
|
CCR (NCI)
|
|
Leukemia Signatures for Risk Classification & Targeting
|
5U01CA114762-03
|
$1,388,594
|
$694,297
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO ALBUQUERQUE
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-03
|
$1,319,186
|
$197,878
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO ALBUQUERQUE
|
|
CANCER CENTER SUPPORT GRANT (CCSG)
|
3P30CA022435-22S2
|
$1,304,917
|
$39,148
|
FOGARTY, JOHN
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
Molecular genetics of MLL-associated leukemia
|
5P01CA105049-03
|
$1,166,954
|
$583,477
|
DIAZ, MANUEL
|
LOYOLA UNIVERSITY CHICAGO
|
|
Human Specimen Banking in NCI-Supported Cancer Clinical
|
5U24CA114766-03
|
$1,133,628
|
$226,726
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Studies of Non-Ionizing Radiation-Related Cancer
|
Z01 CP010135
|
$1,043,074
|
$3,380
|
Inskip
|
DCEG (NCI)
|
|
PEDIATRIC CHTN--AIDS CANCER RESEARCH
|
3U01CA054021-15S2
|
$828,868
|
$99,464
|
QUALMAN, STEPHEN
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Promoting Treatment Adherence in Adolescent Leukemia
|
1R01CA119162-01A1
|
$701,307
|
$701,307
|
DROTAR, DENNIS
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
"Cancer Risk and Environmental Exposures to Nitrate, Pesticides, and Industrial C
|
Z01 CP010153
|
$696,133
|
$521,036
|
Ward
|
DCEG (NCI)
|
|
Cancer Center Support Grant
|
5P30CA042014-20
|
$693,487
|
$6,935
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Zebrafish models of human leukemia and sarcoma
|
Z01 BC 010549
|
$687,101
|
$343,551
|
Hickstein, Dennis
|
CCR (NCI)
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
Z01 SC 010378
|
$636,008
|
$318,004
|
Aplan, Peter
|
CCR (NCI)
|
|
Genetic Consequences of Therapies for Cancer
|
5R01CA104666-03
|
$600,831
|
$600,831
|
BOICE, JOHN
|
VANDERBILT UNIVERSITY
|
|
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)
|
5R37CA036401-24
|
$574,893
|
$574,893
|
EVANS, WILLIAM
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Minimal Residual Disease in Pediatric ALL in Relation to Other Prognostic Factors
|
5R01CA086011-07
|
$542,666
|
$542,666
|
BOROWITZ, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Ethnic Differences in Survival after Childhood ALL
|
5R01CA096670-04
|
$485,753
|
$485,753
|
BHATIA, SMITA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
PHARMACODYNAMICS OF ANTILEUKEMIC AGENTS IN CHILDREN
|
5R01CA078224-10
|
$480,447
|
$480,447
|
EVANS, WILLIAM
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Molecular and Pharmacologic Correletes of Acute Myeloid Leukemia in Down Syndrome
|
1R01CA120772-01A2
|
$463,399
|
$463,399
|
TAUB, JEFFREY
|
WAYNE STATE UNIVERSITY
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-05S2
|
$450,000
|
$238,500
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Biology and Prognostic implications of Flt3 mutations in AML
|
5R01CA114563-03
|
$421,364
|
$210,682
|
MESHINCHI, SOHEIL
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Metabolic Syndrome Following Transplant for Leukemia
|
5R01CA112530-02
|
$420,764
|
$210,382
|
BAKER, KEVIN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
EORTC DATA CENTER
|
5U10CA011488-37
|
$417,479
|
$37,573
|
Sylvester, Richard
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
Development of Recombinant Toxins for Treatment of Patients with Hematologic Mali
|
Z01 BC 010301
|
$405,903
|
$8,118
|
Kreitman, Robert
|
CCR (NCI)
|
|
Biochemistry of Leukemia Virus Core Binding Factor
|
5R01CA058343-14
|
$405,444
|
$202,722
|
SPECK, NANCY
|
DARTMOUTH COLLEGE
|
Total relevant funding to Childhood Leukemia for this search: $44,502,817
|